ABSTRACT. In a patient with a mitochondrial myopathy, presenting with lactic acidosis, "'P-nuclear magnetic resonance spectroscopy in resting muscle showed half the creatine phosphate level of controls. The creatine phosphate resynthesis rate after aerobic exercise was only 18% of that in controls. However, the activities of complexes I to V catalyzing oxidative phosphorylation and the pyruvate and the 2-oxoglutarate dehydrogenase complexes showed a 2-to 20-fold increase. In line with this, the uncoupled mitochondrial respiration rate was significantly higher than in controls. In contrast, the respiration of the mitochondria from the patient was less stimulated by ADP than that of control mitochondria. This finding could point to a defect in complex V, the enzyme directly involved in ATP synthesis. The activity of complex V, measured as the mitochondrial ATPase activity, and its concentration, as judged from Western blots using antisera against the F, part of complex V, were, however, also greatly increased in the patient. Alternatively, the transport system, importing ADP into and exporting ATP out of the mitochondrial matrix, the ADPIATP or adenine nucleotide translocator, could be affected. Immunostaining of Western blots revealed a 4-fold decrease in the concentration of the adenine nucleotide translocator in the patient. Because oxidative phosphorylation was not disturbed in fibroblasts and lymphocytes, we conclude that this patient suffers from a muscle-specific deficiency of his mitochondrial adenine nucleotide translocator, a defect unknown so far. (Pediatr Res 33: 412-41 7, 1993) Abbreviations "P-NMR, 3'P-nuclear magnetic resonance Pi, inorganic phosphate which enables the cells to perform a variety of energy-consuming processes. Mitochondrial energy production requires the uptake of substrates by several import systems. the conversion of these substrates to oxidizable compounds. and. finally. oxidative phosphorylation. During the latter process. electrons derived from oxidizable substrates are transported via the enzymes of the respiratory chain to oxygen (respiration). and a proton gradient is generated over the mitochondrial inner membrane. This gradient is the driving force for the production of ATP by complex V. the ATP synthase (phosphorylation). ATP produced inside the mitochondria is next transported to the cytosol by the adenine nucleotide translocator. This carrier is also responsible for the import of ADP into the mitochondria: ADP is exchanged for ATP.
Mitochondrial defects that impinge directly on mitochondrial energy metabolism can thus be based on dysfunction of one or more of the enzymes involved in the processes described above (I). In addition. many of the enzyme complexes involved in mitochondrial energy production occur as tissue-specific isoforms. Muscle-specific isoforms of complex IV (cytochrome c oxidase) (2) and the adenine nucleotide translocator (3-6) have. for instance. clearly been established. Tissue-specific mitochondrial enzyme defects are therefore also conceivable.
This communication describes investigations of a boy in whom the clinical presentation was strongly suggestive of a mitochondrial myopathy. These myopathies are characterized by structural and/or functional abnormalities of the mitochondria (1. 7-10). Most of the patients suffering from these diseases show an increased lactate level and/or abnormal concentration of organic acids in body fluids. Usually. one or more of the enzymes involved in mitochondrial energy production is found to be deficient. In the boy under study, however, we found an impressively increased activity of all the mitochondrial enzymes that can be tested in a muscle biopsy. This required further investigations into the nature of the defect, usingalternative approaches.
ADENINE NUCLEOTlDE TR
Clinical and neurologic investigations showed a slightly dystrophic child with a normal muscle tone.
In serum. lactate was 1 1.8 mM (controls <2.0). pyruvate 15 1 pM (controls 41-70). and alanine 453 pM (controls 150-300). In cerebrospinal fluid. lactate was 3.3 m M (controls <1.8) and alanine 38 pM (controls 12-32). In urine. the concentration of lactate was also increased (13.9 mmol/mmol creatinine) and high levels of ketone bodies were found. Free and total carnitine levels were normal in blood and urine.
Histochemical examination of muscle (musculus quadriceps) showed no ragged red fibers. Electron microscopy revealed abnormal mitochondria containing crystalline structures. Biochemical investigations of a homogenate from frozen muscle demonstrated increased activities of the respiratory chain enzymes and complex V, pyruvate dehydrogenase, and 2-oxoglutarate dehydrogenase.
In the absence of clues pointing to the nature of this disease. and because of its severity, a therapeutic trial was initiated with L-carnitine ( After 23 mo. his clinical condition worsened again and serum lactate increased. Because of the possibility of a subtle defect in complex I or coenzyme Q not detectable in frozen muscle (I I), menadione (75 mg/d) and succinate (3 g/d) were given orally but remained without effect. A second muscle biopsy was taken for investigations of intact mitochondria. Whereas most mitochondrial enzyme activities in the homogenate again were found to be increased, oxidative phosphorylation by intact mitochondria was defective. This was confirmed by in vivo "P-NMR spectroscopy of the muscle.
After discontinuation of the therapeutic measures. the patient's appetite improved, but serum lactate rose to 12.7 mM and pyruvate to 286 pM. and "P-NMR spectroscopy showed the same results as before. He attends a normal school and is among the best pupils of his class in all subjects except gymnastics.
Mziscle hiochetnistrj~ offirst hiopsj.. The assays on muscle from the first biopsy were performed in homogenates. Protein. total carnitine, the activities of total creatine kinase, rotenone-sensitive NADH oxidase (complex I). succinate dehydrogenase (complex 11). antimycin-sensitive succinate-cytochrome c reductase (complex I1 + 111). and cytochrome c oxidase (complex IV) were measured as described by Scholte et al. Oligomycin-sensitive. uncoupler-stimulated Mg2+-ATPase (complex V) activity was measured as described bv Scholte et al. (I I) . 'in the' presence of the uncoupler 2.4-dinit;ophenol (and 2.5% ethanol) as the difference between the activity with and without oligomycin (25 pg/mL). Pyruvate dehydrogenase activity was measured after preincubation with Mg2+-ATP followed by Ca" plus Mg". The activity of this enzyme and also of the 3-oxoglutarate dehydrogenase complex was measured according to
Muscle hiocliemistrj~ of second hiopsj.. Because of the limited amount of biopsy material. isolation and purification of mitochondria was excluded. Activities of oxidative phosphorylation in the second biopsy were therefore measured in a supernatant (10 min. 600 x g) of a homogenate of freshly biopsied muscle, which is an appropriate alternative for isolated mitochondria (13, 14) . The activities of total creatine kinase. rotenone-sensitive NADH-ubiquinone-l oxidoreductase (complex I). succinate-cytochrome c reductase (complex 11 + 111). cq-tochrome c oxidase (complex IV). pyruvate dehydrogenase. 2-oxoglutarate dehydrogenase, citrate synthase. as well as substrate oxidation rates and ATP production rates of intact mitochondria, were assayed as described by Fischer et al. (13) and Van Laack et al. (14) . The final concentration of the uncoupler m-chlorocarbonyl cyanide phenylhydrazine was 2 pM. Mitochondria1 creatine kinase was ANSLOCATOR DEFICIENCY 413 determined according to the method outlined by Smeitink et al. ( 15) . The other assays were as described for the first biopsy.
Patients suspected of having a neuromuscular disorder, without biochemical and morphologic evidence of such a disorder were taken as controls. The age of the controls was between 2 m o and 60 y. For this age range. no statistically significant differences were found for the activities and amounts measured between different age groups or between males and females.
"P-NMR spcctroscopj*. "P-NMR spectroscopic measurement of in I~~I Y I levels of creatine phosphate. ATP, and Pi in skeletal muscle in the resting state was performed at the age of 5 , 7, and 8 using a 1.5 T Philips SI 5/HP Gyroscan unit (Philips Medical Systems, Best, The Netherlands). In addition, the rate of creatine phosphate resynthesis after aerobic exercise. reflecting the in vivo capacity of mitochondrial ATP synthesis (16-1 8) . was measured at the age of 8 y.
The patient was positioned prone and head-first on the patient bed. with his right arm extended forward. The muscle belly of the forearm was placed over a 5-cm single-turn double-tunable 'H/"P surface coil. The sampled muscle mass consisted of both finger and wrist flexor muscles. After adjustment of the local Bo field homogeneitv (0.25-0.33 ppm), "P-NMR spectra of superficial skeletal muscle ofthe forearm were obtained at 25.86 MHz. using an adiabatic half-passage excitation pulse with a length of 3 ms. sweep width 3 kHz (1024 points). and repetition time of 3 s. For the measurement of relative creatine phosphate. ATP, and Pi levels in skeletal muscle in the resting state, 100 acquisitions were averaged. During the creatine phosphate recovery measurement. "P-NMR spectra were obtained at rest. during aerobic steady-state exercise. and during recovery in I-min blocks for 10 min. Exercise was performed by squeezing a plastic air bulb once ever 4 s during 3 min.
Free induction decays were processed on a Sun Sparc 330 workstation. using the LAB ONE (New Methods Research, Inc., Syracuse, New York) NMRl spectroscopy processing software. The decays were exponentially filtered. resulting in a 10-Hz line broadening. and zero-filled to 2048 data points before Fourier transformation. After manual phasing. baseline correction was performed by baseline deconvolution using computer-estimated flattening parameters. Estimates of the relative peak areas of the phosphates were obtained by curve fitting of the spectrum of Lorentzian line shapes. Global intracellular pH was estimated from the chemical shift of Pi relative to creatine phosphate.
The time constants k of the creatine phosphate resynthesis rate and the Pi disappearance rate were estimated from the fit of the changes in creatine phosphate (expressed as percentages of the initial levels) with time to a single exponential function (18) using the Enzfitter software (version 1.05. Elsevier Biosoft. Cambridge. UK). Statistical comparisons were made using a paired I test.
,Muscle imtnut~ohiochet~ii~rtrj~ of second biopsj,. Frozen muscle biopsies (about 50 mg) were homogenized and suspended to 10% (mass/vol) in ice-cold buffer (0.25 M sucrose. I mM Tris-HCI. pH 7.4) containing a mixture of protease inhibitors (19). Laurylmaltoside (final concentration 1.5%) was added to the homogenate to solubilize the proteins. The samples were directly used or stored in liquid nitrogen. The proteins in the samples were resolved by polyacnlamide gel electrophoresis in the presence of sodium dodecyl sulfate. Western blotting and immunodetection of the proteins were performed as described elsewhere (19). Polyclonal antisera against the F I part of complex V and the adenine nucleotide translocator. both isolated from rat liver mitochondria. were a kind gift of Dr. K. Luciakova and coworkers (Cancer Research Institute. Bratislava, Czechoslovakia). These antisera showed a clear cross-reactivity with the respective mitochondrial proteins from both human liver and human muscle. Antisera against cytochrome c oxidase from bovine heart were obtained as described before (1 9).
Formation nf lactate and pj3rzr1vate .from gl~rcose in cultured skin .fibroblasts. Human skin fibroblasts were grown from ex- Scotland) . supplemented with 7.5% (vol/vol) FCS. 7.5% (vol/vol) newborn calf serum, 3 mM glutamine. 10 mM NaHCO?. 20 mM HEPES (IL-2-hydroxyethylpiperazine-.h"-2-ethanesulfonic acid), 100 U/mL penicillin, 100 pg/mL streptomycin. and 0.25 pg/mL fungizone in an atmosphere of 5% (vol/vol) carbon dioxide in air. To study glucose metabolism. cells were grown in 25-cm' culture flasks and incubated in a medium containing Krebs-Henseleit bicarbonate buffer plus 20 mM HEPES (pH 7.4) and 5 mM glucose. The production of lactate and pyruvate was measured after 4 h at 37°C.
BAKKER
A TP synthesis in permeabilized lymphocytes. Lymphocytes were isolated according to standard procedures from blood obtained from control subjects and our patient, and finally suspended in PBS (140 mM NaCI, 9.2 mM Na2HP04, and 1.3 mM NaH2P04. pH 7.4) plus I % (wt/vol) BSA (fatty acid-free). Subsequently. the lymphocytes (final concentration 0.3 mg protein/ mL) were incubated in a medium containing 150 mM KCI, 25 mM Tris-HCI. 2 mM sodium EDTA. 10 mM potassium phosphate (final pH 7.4). plus 75 pg/mL digitonine to permeabilize the cells. After 5 min at 25°C. ATP synthesis was initiated by adding ADP (final concentration 10 mM) and oxidizable substrates. which included 10 mM glutamate plus 10 mM malate, 10 mM pyruvate plus 10 mM malate, 20 mM succinate (in the presence of 20 pg/mL rotenone), and 10 mM ascorbate plus 0.5 mM N,N.N'-N'-tetramethyI-p-phenylenediamine-dihydrochloride. Reactions were terminated after 10 min by adding perchloric acid (0.5 N final concentration). Subsequent work-up of samples and measurement of ATP was done as described before (2 1).
RESULTS
Muscle bioc,hemi.str!.. The activities of a number of enzymes as measured in muscle homogenates of the patient are shown in Table 1 . In the first biopsy (before treatment), the activity of respiratory chain enzymes (complexes I, 11, I1 + 111. and IV), as well as the activities of complex V, pyruvate dehydrogenase, and 2-oxoglutarate dehydrogenase, were 1.9-to 19.9-fold increased, whereas the muscle contents of protein, total carnitine, and the total creatine kinase activity were in the normal range.
The second muscle biopsy (during treatment) showed that the activities of citrate synthase and mitochondrial creatine kinase also were strongly increased and confirmed the increased activities of complexes I, 11, 11 + 111, V and 2-oxoglutarate dehydrogenase. The activity of pyruvate dehydrogenase was again found to be increased but less than in the first biopsy. The activity of cytochrome c oxidase had normalized (Table 1) .
The mitochondrial capacity to oxidize pyruvate plus malate and the resulting energy production were measured in a supernatant prepared from freshly biopsied muscle ( Table 2 ). The oxidation rate of pyruvate was stimulated by ADP by a factor of 2.7, compared with 7.0 in the average controls, and addition of uncoupler m-chlorocarbonyl cyanide phenylhydrazine stimulated the oxidation rate by a factor of 15.7, compared with 7.0 in the controls, to an abnormally high value of 1974 nmol I4CO2.
h-' . (mg protein)-' versus a control range of 260 to 700. Coupled and uncoupled respiration show about the same velocity in the controls. From the great difference between these activities in the patient, it can be concluded that the patient has a severe defect in the mitochondrial phosphorylation.
The phosphorylation defect was further supported by the finding that the energy production from pyruvate plus malate was barely normal. This resu!ted in a E C !~ ratio ef high-energy phosphates over pyruvate oxidized of 5.4 in the patient versus 10.0 in the average controls.
The phosphorylation defect is unlikely to result from a deficiency of complex V because the activity of this complex, measured as mitochondrial ATPase. was increased 4.7-fold compared with controls (Table 1 ) .
"P-IV.C/R spc.c'troscopj.. An overview of the relative creatine phosphate. Pi. and ATP content. and the intracellular pH of the patient's skeletal muscle in the resting state versus healthy controls. is given in Table 3 . Most importantly. the creatine phosphate content of the patient's skeletal muscle was significantly decreased by a factor of 2 in comparison with controls ( p < 0.01), whereas the Pi content was significantly increased ( p < 0.01). Intracellular pH was normal. These findings were similar for all three examinations conducted at different ages (5 to 8 y) .
In the creatine phosphate recovery measurement conducted at the age of 8 y, the 31P-NMR spectra obtained during exercise showed that the global intracellular pH within the sampled muscle mass had only slightly decreased to 6.95. This absence of any significant intracellular acidosis validated fitting of the creatine phosphate recovery kinetics to a single exponential function (18) . The global creatine phosphate content of the sampled muscle mass had decreased to 50% of its initial value during exercise. The time constant k for the rate of creatine phosphate recovery to the resting level was significantly decreased in the patient's skeletal muscle to 18% of that in healthy controls (Table  3 ). In the recovery phase. the rate of Pi disappearance was 24% of that in controls. This decrease is to be expected because the charge difference resulting from ATP-export and ADP3-import necessitates the respiratory chain to export I H' , which recycles back to the matrix with H,P04-by the action of the phosphate translocator. This activity must be in pace with that of the adenine nucleotide translocator to maintain electroneutrality. The fact that the rate of Pi disappearance was higher than that of creatine phosphate recovery (Table 3) suggests that the pacing is not as strict and the phosphate translocator is not rate-limiting in creatine phosphate resynthesis.
Immunobiochemtry qf'musclr. For the analysis of the concentration of mitochondrial enzymes. gels were loaded with samples from patient and control muscle homogenates that contained a comparable amount of protein. Differences in the mobility of immunoreactive subunits were not observed after immunostaining of blots incubated with antisera against F, of complex V and cytochrome L' oxidase (Fig. I ) and the adenine nucleotide translocator (Fig. 2) . However, differences in the concentration of the respective proteins were clearly visible. The concentration of immunoreactive subunits of cytochrome c oxidase as well as F, in the samples from the patient showed a 5-to 10-fold increase compared with the control, whereas protein. immunoreacting with adenine nucleotide translocator antiserum was about 4-fold decreased. This agreed with the increased activity of the F,-ATPase (complex V in Table I ) but contrasted with the normal activity of cytochrome c oxidase (complex IV in Table 1) . 0,uidative phosphorvlation in jibroblasrs and 1.vmphocytes. To detect if the defect was expressed in cell types other than muscle, studies were performed in cultured skin fibroblasts and lymphocytes. In fibroblasts of the patient, the production of lactate and pyruvate from glucose, as well as the lactate/pyruvate ratio. was normal. Pyruvate carboxylase also showed a normal activity.
In permeabilized lymphocytes, we measured the synthesis of ATP from ADP plus phosphate using the various oxidative substrates. The results showed normal rates of ATP synthesis with each of the different substrates.
DISCUSSION
To the best of our knowledge, this is the first description of a patient with a mitochondrial myopathy in whom all the available evidence points to a rnude-specific deficiency of the adenine nucleotide translocator as the primary cause of the disease. The most direct evidence to support this conclusion is the decreased amount of protein immunoreacting with an antiserum against the adenine nucleotide translocator in the muscle of the patient. C'ot7ct.nrr~ltion.s qfprotc'in and c.arnirinc on(i acrivitic~~ ( ! / ' l~[ a l c.reutine X-ina. Creatine kinase activity (rmol/min/g wet wt) Complex I activity (rmol NADH/min/g wet wt) Complex I1 activity (rmol/min/g wet wt)
Complex I1 + 111 activity (pmol/min/g wet wt) Complex IV activity (first-order rate constant/min/g wet wt) Complex V activity (pmol/min/g wet wt) Pyruvate dehydrogenase activity (pmol/ min/g wet wt) 2-Oxoglutarate dehydrogenase activity (fimol/min/g wet wt)
Data from laboratory I1 (/mg protein) Creatine kinase activity (pmol/min/mg protein) Complex 1 activity (nmol/min/mg protein)
Complex I1 + Ill activity (nmol/min/mg protein) Complex IV activity (nmol/min/mg protein) Pyruvate dehydrogenase activity (nmol/ min/mg protein) 2-Oxoglutarate dehydrogenase activity (nmol/min/mg protein) Citrate synthase activity (nmol/min/mg protein) Mitochondria1 creatine kinase activity (pmol/min/mg protein) * I is the first biopsy at age 3.5 y before treatment and 2 the second biopsy at the age of 5.5 y on treatment. A. muscle homogenate: B. 10-min 600 X g supernatant: n, no. of controls. Enzyme activities are expressed in indicated amount of substratelmin. This antiserum was raised against the adenine nucleotide translocator. isolated as described by Schultheiss er al. (22) . from rat liver mitochondria. It shows a highly specific reactivity to the adenine nucleotide translocator of various mammalian species. including man (data not shown). and reacts indiscriminately with the different tissue-specific isoforms of the translocator.
The decrease in adenine nucleotide translocator protein in the patient could be explained by decrease in antigeneity of a mutant protein. However. the faint translocator band in the patient could also reflect a deficiency of the muscle-specific adenine nucleotide translocator isoform. an explanation strongly supported by the tissue specificity of the mitochondria1 defect. Moreover. preliminary results of transcript analysis with isoform-specific probes show a severely reduced level of the transcript of the musclespecific adenine nucleotide translocator gene in the patient's muscle as compared with controls.
Regardless of the precise genetic nature of the defect. deficiency of the adenine nucleotide translocator fully explains the results obtained in the functional analysis of the muscle mitochondria from the patient. The decreased stimulation of respiration by 4 16 BAKKER ADP and the increase in respiration by uncoupler have to be expected in tightly coupled mitochondria with a high ATP/ADP in the matrix as a consequence of the adenine nucleotide translocator deficiency.
The increased activity of almost all other mitochondrial enzymes might be a secondary effect: hyperproliferation of rnitochondria or an enhanced synthesis of mitochondrial enzymes is a common phenomenon in patients with mitochondrial myopathies and m-ight be regarded as an attempt to compensate for the decreased function of individual mitochondria. Com~ared with the other mitochondrial enzymes. the activity of complex IV was much less increased in the first biopsy and normal in the second one. However, the amount of immunoreactive protein of complex IV was increased several-fold. The nature of this discrepancy between concentration and aciivity is not known and deserves further research. Despite the increase in the capacity for (uncoupled) respiration, reflecting the increased activity of the enzymes involved. the energy production of the mitochondria in the muscle of the patient was severely affected, as is most clearly illustrated by the "P-NMR data. A 50% decrease in creatine phosphate levels in the resting muscle is encountered only in patients with severe defects in mitochondrial energy metabolism. Impairment of oxidative phosphorylation will lead to the accumulation of glycolytic NADH and pyruvate. In turn, this leads to an enhanced production of lactate in the muscle of the patient. Excess lactate will be pumped away to the blood. The severity of the metabolic block is further demonstrated by the very high lactate levels in the blood of the patient. The increased lactate level in the cerebrospinal fluid is possibly due to overflow from the blood compartment, where the level is much higher. Liver and heart were. according to clinical investigations, completely healthy. Also, involvement of the brain is not likely in light of the patient's intellectual abilities. Moreover. investigations of lymphocytes and fibroblasts did not show indications of abnormal oxidative phosphorylation.
Taken together, the results indicate that the patient described has a mitochondrial disease that is confined to his skeletal muscle, and all the evidence points to a deficiency of the adenine nucleotide translocator as the primary cause. Inhibition of the function of the adenine nucleotide translocator has been reported to occur in secondary mitochondrial pathology (23-28). In these patients. however, the clinical pattern, including the type of organs and tissues involved, is completely different. Moreover, although in these patients the activity of the adenine nucleotide translocator is affected, the concentration of the protein is not. Therefore, the most likely explanation for the molecular background of the muscle-specific disease in our patient is an impaired expression of the gene encoding the muscle-specific form of the adenine nucleotide translocator.
